Oncolytics Biotech Inc (ONCY) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.07
• Market Cap: $119.44M
• EPS: $-0.29
• 52-Week High: $1.51
• 52-Week Low: $0.33

Market Sentiment

Oncolytics Biotech Inc currently has a Bullish sentiment score of 0.41.

About Oncolytics Biotech Inc

Oncolytics Biotech Inc. (ONCY) is a Calgary-based clinical-stage biopharmaceutical company focused on pioneering oncolytic virus therapies for cancer treatment. Its leading candidate, pelareorep, uniquely targets cancer cells while enhancing the body’s immune response against tumors. With a robust pipeline and ongoing clinical trials, Oncolytics aims to deliver innovative solutions for patients with a range of cancers. The company leverages strategic collaborations and a strong research backg...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Oncolytics Biotech Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ONCY pay dividends?

Oncolytics Biotech Inc (ONCY) does not currently pay a regular dividend.

What is ONCY's market cap?

Oncolytics Biotech Inc (ONCY) has a market capitalization of $119.44M with a current stock price of $1.07.